| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8785280 | Brachytherapy | 2018 | 8 Pages |
Abstract
Time-driven activity-based costing analysis identified higher delivery costs associated with prostate BT compared with IMRT alone. In light of recent guidelines promoting BT for intermediate- to high-risk disease, re-evaluation of payment policies is warranted to encourage BT delivery.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Sunil W. Dutta, Kristine Bauer-Nilsen, Jason C. Sanders, Daniel M. Trifiletti, Bruce Libby, Donna H. Lash, Melody Lain, Deborah Christodoulou, Constance Hodge, Timothy N. Showalter,